Previous close | 50.70 |
Open | 50.70 |
Bid | 46.20 |
Ask | 46.90 |
Strike | 220.00 |
Expiry date | 2024-06-21 |
Day's range | 50.70 - 50.70 |
Contract range | N/A |
Volume | |
Open interest | 30 |
Danaher (DHR) closed the most recent trading day at $254.46, moving -0.3% from the previous trading session.
Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology innovator, today announced it will provide Cepheid's Xpert® MTB/RIF Ultra diagnostic test cartridges for tuberculosis (TB) at Cepheid's cost of $7.97 each to the Global Fund to Fight AIDS, TB and Malaria ("the Global Fund") and to less-developed countries eligible for Cepheid's Global Access Program1 to support greater access to high-quality TB testing. The Global Fund is the largest provider of financing and programs t
Danaher (DHR) closed the most recent trading day at $253.77, moving -0.58% from the previous trading session.